Protein kinetics in human endotoxaemia and their temporal relation to metabolic, endocrine and proinflammatory cytokine responses

British Journal of Surgery

Volumn 102, Issue 7, 2015, Pages 767-775

  Khan, A S A ^a   Gibson, J M ^a   Carlson, G L ^a   Rooyackers, O ^b   New, J P ^a   Soop, M ^a  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROTEIN;

ADULT; BLOOD; ENDOTOXEMIA; FOLLOW UP; HUMAN; INFLAMMATION; KINETICS; MALE; METABOLISM; NORMAL HUMAN; RADIOIMMUNOASSAY;

ADULT; CYTOKINES; ENDOTOXEMIA; FOLLOW-UP STUDIES; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; KINETICS; MALE; PROTEINS; RADIOIMMUNOASSAY;

EID: 84929657716     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9817     Document Type: Article

References (46)

1. Vincent J-L, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al,. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med 2014; 2: 380-386.
2. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al,. Surviving Sepsis Campaign. Crit Care Med 2013; 41: 580-637.
3. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, et al,. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-693.
4. Ali NA, O'Brien JM, Hoffmann SP, Phillips G, Garland A, Finley JC, et al,. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178: 261-268.
5. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL,. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000; 85: 3770-3778.
6. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, et al,. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-1486.
7. Lowry SF,. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 2005; 24: 94-100.
8. Bloesch D, Keller U, Spinas GA, Kury D, Girard J, Stauffacher W,. Effects of endotoxin on leucine and glucose kinetics in man: contribution of prostaglandin E2 assessed by a cyclooxygenase inhibitor. J Clin Endocrinol Metab 1993; 77: 1156-1163.
9. Fong YM, Marano MA, Moldawer LL, Wei H, Calvano SE, Kenney JS, et al,. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 1990; 85: 1896-1904.
10. Soop M, Duxbury H, Agwunobi AO, Gibson JM, Hopkins SJ, Childs C, et al,. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab 2002; 282: E1276-E1285.
11. van der Crabben SN, Blümer RM, Stegenga ME, Ackermans MT, Endert E, Tanck MW, et al,. Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans. J Clin Endocrinol Metab 2009; 94: 463-468.
12. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, et al,. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2009; 59: 172-181.
13. Fong Y, Matthews DE, He W, Marano MA, Moldawer LL, Lowry SF,. Whole body and splanchnic leucine, phenylalanine, and glucose kinetics during endotoxemia in humans. Am J Physiol 1994; 266: R419-R425.
14. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Møller K,. Human endotoxemia as a model of systemic inflammation. Curr Med Chem 2008; 15: 1697-1705.
15. Abumrad NN, Rabin D, Diamond MP, Lacy WW,. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metab Clin Exp 1981; 30: 936-940.
16. Liu D, Moberg D, Kollind M, Lins P-E, Adamson U, Macdonald IA,. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycemia and hypoglycemia. Diabetologia 1992; 35: 287-290.
17. Ferrannini E., The theoretical bases of indirect calorimetry: a review. Metab Clin Exp 1988; 37: 287-301.
18. 3]-3-methylhistidine: a new method. Metab Clin Exp 2004; 53: 1076-1080.
19. 5]phenylalanine model. Am J Physiol 1989; 256: E631-E639.
20. Short K, Meek S, Moller N, Ekberg K, Nair K,. Whole body protein kinetics using Phe and Tyr tracers: an evaluation of the accuracy of approximated flux values. Am J Physiol 1999; 276: E1194-E1200.
21. Gill MS, Whatmore AJ, Tillman V, White A, Addison GM, Price DA, et al,. Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group. Clin Endocrinol (Oxf) 1997; 46: 483-492.
22. Westwood M, Gibson JM, Davies AJ, Young RJ, White A,. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 1994; 79: 1735-1741.
23. Rooyackers O, Kouchek-Zadeh R, Tjäder I, Norberg Å, Klaude M, Wernerman J,. Whole body protein turnover in critically ill patients with multiple organ failure. Clin Nutr 2015; 34: 95-100.
24. Streat S, Beddoe A, Hill G,. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987; 27: 262-266.
25. Gamrin L, Essén P, Hultman E, McNurlan MA, Garlick PJ, Wernerman J,. Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Ann Surg 2000; 231: 577-586.
26. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al,. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792.
27. Suffredini AF, Hochstein HD, McMahon FG,. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J Infect Dis 1999; 179: 1278-1282.
28. Vesali RF, Klaude M, Rooyackers O, Wernerman J,. Amino acid metabolism in leg muscle after an endotoxin injection in healthy volunteers. Am J Physiol Endocrinol Metab 2005; 288: E360-E364.
29. Vesali RF, Cibicek N, Jakobsson T, Klaude M, Wernerman J, Rooyackers O,. Protein metabolism in leg muscle following an endotoxin injection in healthy volunteers. Clin Sci 2010; 118: 421-427.
30. Cotterill AM, Holly JM, Wass JA,. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting. Clin Endocrinol (Oxf) 1993; 39: 357-362.
31. Lang CH, Pollard V, Fan J, Traber LD, Traber DL, Frost RA, et al,. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am J Physiol 1997; 273: R371-R378.
32. Copeland KC, Nair KS,. Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab 1994; 78: 1040-1047.
33. Starnes HF, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, et al,. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 1988; 82: 1321-1325.
34. Warren RS, Starnes HF, Gabrilove JL, Oettgen HF, Brennan MF,. The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 1987; 122: 1396-1400.
35. Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH,. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am J Physiol Endocrinol Metab 2005; 288: E493-E501.
36. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA,. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 1996; 97: 1111-1116.
37. McNicol FJ, Hoyland JA, Cooper RG, Carlson GL,. Skeletal muscle contractile properties and proinflammatory cytokine gene expression in human endotoxaemia. Br J Surg 2010; 97: 434-442.
38. van Hall G, Steensberg A, Fischer C, Keller C, Møller K, Moseley P, et al,. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab 2008; 93: 2851-2858.
39. van Hall G., Cytokines: muscle protein and amino acid metabolism. Curr Opin Clin Nutr Metab Care 2012; 15: 85-91.
40. van Hees HW, Schellekens W-JM, Linkels M, Leenders F, Zoll J, Donders R, et al,. Plasma from septic shock patients induces loss of muscle protein. Crit Care 2011; 15: R233.
41. Nygren J, Nair K,. Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes 2003; 52: 1377-1385.
42. van Eijk LT, Dorresteijn MJ, Smits P, van der Hoeven JG, Netea MG, Pickkers P,. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med 2007; 35: 1464-1469.
43. Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, Nijjar PS, et al,. Race and gender variation in response to evoked inflammation. J Transl Med 2013; 11: 63.
44. Krabbe KS, Bruunsgaard H, Hansen CM, Møller K, Fonsmark L, Qvist J, et al,. Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 2001; 8: 333-338.
45. van Eijk LT, van der Pluijm RW, Ramakers BP, Dorresteijn MJ, van der Hoeven JG, Kox M, et al,. Body mass index is not associated with cytokine induction during experimental human endotoxemia. Innate Immun 2013; 20: 61-67.
46. Fryburg DA, Gelfand RA, Jahn LA, Oliveras D, Sherwin RS, Sacca L, et al,. Effects of epinephrine on human muscle glucose and protein metabolism. Am J Physiol 1995; 268: E55-E59.